Day One Biopharmaceuticals
DAWN
6,13 €
Share price
-1.80%
Change (1 day)
-56.85%
Change (1 year)
Categories
Earnings for Day One Biopharmaceuticals (DAWN)
Earnings in 2025 (TTM): -€0.19 Billion
According to Day One Biopharmaceuticals's latest financial reports the company's current earnings are €0.16 Billion. In 2024 the company made an earning of -€0.19 Billion a decrease over its 2023 earnings that were of -€0.18 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Day One Biopharmaceuticals from 2020 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -€0.19 Billion | -3.4% |
| 2024 | -€0.19 Billion | 5.44% |
| 2023 | -€0.18 Billion | 40.27% |
| 2022 | -€0.13 Billion | 102.06% |
| 2021 | -€62.73 Million | 65.94% |
| 2020 | -€37.8 Million |